Search

Your search keyword '"Thomas J. Evans"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Thomas J. Evans" Remove constraint Author: "Thomas J. Evans"
179 results on '"Thomas J. Evans"'

Search Results

101. Flame retardants and legacy contaminants in polar bears from Alaska, Canada, East Greenland and Svalbard, 2005-2008

102. Purification of a distinctive form of endotoxin-induced nitric oxide synthase from rat liver

103. Bacterial triggering of inflammation by intracellular sensors

104. Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects

105. Modulation of lamellipodial structure and dynamics by NO-dependent phosphorylation of VASP Ser239

106. POWER for reproductive health: results from a social marketing campaign promoting female and male condoms

107. Trace element concentrations in livers of polar bears from two populations in Northern and Western Alaska

108. Temporal trends of perfluoroalkyl contaminants in polar bears (Ursus maritimus) from two locations in the North American Arctic, 1972-2002

109. Brominated flame retardants in polar bears (Ursus maritimus) from Alaska, the Canadian Arctic, East Greenland, and Svalbard

110. Opportunities to replace the use of animals in sepsis research. The report and recommendations of a Focus on Alternatives workshop

111. Circumpolar study of perfluoroalkyl contaminants in Polar Bears (Ursus maritimus)

112. Expression and functions of the duodenal peptide secretin and its receptor in human lung

113. Bioassay for Tumor Necrosis Factors-α and β

114. Auto-immune neutropenia occurring in association with malignant melanoma

115. Polar Bear Aerial Survey in the Eastern Chukchi Sea: A Pilot Study

116. Block sequential adriamycin CMF – optimal non-myeloablative chemotherapy for high risk adjuvant breast cancer?

117. Role of the PDZ scaffolding protein in tubule cells in maintenance of polarised function

118. Atypical presentation of malignant hyperthermia

119. WS2.8 Genotypic and transcriptomic characterization of a small colony variant of Pseudomonas aeruginosa and its parent strain isolated in a murine model of chronic bacterial colonization

120. Macrophage Nitric Oxide Synthase Associates with Cortical Actin but Is Not Recruited to Phagosomes

121. A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer

122. Accumulation of perfluorooctane sulfonate in marine mammals

123. 123 Anti-tumor activity of CXR1002, a novel anti-cancer clinical phase compound that induces ER stress and inhibits PIM kinases: Human tumor xenograft efficacy and in vitro mode of action

124. Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy

125. Bioassay for tumor necrosis factors-alpha and -beta

126. Septic Shock Methods and Protocols

127. Adequacy of clinical formulae for estimation of energy requirements in children with cystic fibrosis

128. Energy balance during acute respiratory exacerbations in children with cystic fibrosis

130. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages

131. Cytokine Control of Nitric Oxide Production: Therapeutic Possibilities

133. Systemic cytokine response to hepatic resections under total vascular exclusion

134. The Lonmin-Inco Sudbury PGM joint venture: An integrated geophysical and geological search for low-sulphide high-PGE-Au mineralization in the Sudbury Basin

135. Analysis of 2,4,6-trichloroanisole in wines using solid-phase microextraction coupled to gas chromatography-mass spectrometry

136. Cytokine Regulation of Inducible Nitric Oxide Synthase

137. S105 Innate B1 cells are a novel source of IL-17 in chronic pulmonary Pseudomonas aeruginosa infection

138. S100 Novel T helper cell responses against Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis

140. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria

141. Mediators: Nitric Oxide and Other Toxic Oxygen Species

142. The discovery of cyclin (II)

143. mTOR signaling is a promising therapeutic target in a subset of human pancreatic ductal adenocarcinomas

144. CXCR2 inhibition protects against chronic pancreatitis in a murine model

145. Viridans streptococcal bacteraemia: a clinical survey

146. Inhibition of nitric oxide synthase in experimental gram-negative sepsis

147. Inducible nitric-oxide-synthase mRNA is transiently expressed and destroyed by a cycloheximide-sensitive process

148. Contents Vol. 10, 2002

149. Subject Index Vol. 10, 2002

150. Brivanib (BMS-582664) in advanced soft-tissue sarcoma (STS): Biomarker and subset results of a phase II randomized discontinuation trial

Catalog

Books, media, physical & digital resources